HEADER TRANSFERASE 11-AUG-09 3IMX TITLE CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE IN COMPLEX WITH A SYNTHETIC TITLE 2 ACTIVATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 16-465; COMPND 5 SYNONYM: HEXOKINASE 4, MATURITY ONSET DIABETES OF THE YOUNG 2, COMPND 6 ISOFORM CRA_B; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GCK, HCG_1745191, TCAG7.801; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS SUGAR KINASE, ATP-BINDING, GLYCOLYSIS, KINASE, NUCLEOTIDE-BINDING, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.STAMS,B.VASH REVDAT 5 06-SEP-23 3IMX 1 HETSYN REVDAT 4 29-JUL-20 3IMX 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 SITE REVDAT 3 01-NOV-17 3IMX 1 REMARK REVDAT 2 13-OCT-09 3IMX 1 JRNL REVDAT 1 06-OCT-09 3IMX 0 JRNL AUTH G.R.BEBERNITZ,V.BEAULIEU,B.A.DALE,R.DEACON,A.DUTTAROY,J.GAO, JRNL AUTH 2 M.S.GRONDINE,R.C.GUPTA,M.KAKMAK,M.KAVANA,L.C.KIRMAN,J.LIANG, JRNL AUTH 3 W.M.MANIARA,S.MUNSHI,S.S.NADKARNI,H.F.SCHUSTER,T.STAMS, JRNL AUTH 4 I.ST DENNY,P.M.TASLIMI,B.VASH,S.L.CAPLAN JRNL TITL INVESTIGATION OF FUNCTIONALLY LIVER SELECTIVE GLUCOKINASE JRNL TITL 2 ACTIVATORS FOR THE TREATMENT OF TYPE 2 DIABETES. JRNL REF J.MED.CHEM. V. 52 6142 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19746978 JRNL DOI 10.1021/JM900839K REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1397300.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.3 REMARK 3 NUMBER OF REFLECTIONS : 28292 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1410 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3405 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 182 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3493 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 276 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.58000 REMARK 3 B22 (A**2) : 8.16000 REMARK 3 B33 (A**2) : -7.58000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.360 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.450 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 47.21 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : LBX192.PAR REMARK 3 PARAMETER FILE 5 : GLUCOSE.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : LBX192.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : GLUCOSE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3IMX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054611. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : VARIMAX OPTICS REMARK 200 OPTICS : VARIMAX REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.10600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.2 REMARK 200 STARTING MODEL: 1V4S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 10MG/ML IN 20MM TRIS PH 7.5, REMARK 280 50MM NACL, 5MM TCEP, 20MM GLUCOSE 300UM LBX192 WELL: 4C 100MM REMARK 280 HEPES PH 6.0 20% PEG 3350 200MM NACL CRYO: WELL PLUS 20% REMARK 280 GLYCEROL + 100UM LBX192, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.75000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.10000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.10000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.75000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 94 REMARK 465 GLU A 95 REMARK 465 GLU A 96 REMARK 465 GLY A 97 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 417 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 82 -36.09 -137.80 REMARK 500 PRO A 111 -153.19 -55.57 REMARK 500 ASP A 113 40.64 -73.48 REMARK 500 ALA A 114 -65.85 -146.67 REMARK 500 SER A 151 48.22 -80.18 REMARK 500 ASN A 166 148.13 -173.16 REMARK 500 ALA A 173 112.17 170.57 REMARK 500 ALA A 201 146.75 -172.29 REMARK 500 ARG A 358 66.65 -116.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 467 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 238 O REMARK 620 2 VAL A 241 O 87.6 REMARK 620 3 VAL A 244 O 150.5 82.7 REMARK 620 4 GLY A 246 O 86.1 173.4 101.9 REMARK 620 5 HOH A 694 O 108.5 92.8 99.8 91.1 REMARK 620 N 1 2 3 4 DBREF 3IMX A 16 465 UNP Q53Y25 Q53Y25_HUMAN 16 465 SEQADV 3IMX GLY A 11 UNP Q53Y25 EXPRESSION TAG SEQADV 3IMX PRO A 12 UNP Q53Y25 EXPRESSION TAG SEQADV 3IMX GLY A 13 UNP Q53Y25 EXPRESSION TAG SEQADV 3IMX SER A 14 UNP Q53Y25 EXPRESSION TAG SEQADV 3IMX MET A 15 UNP Q53Y25 EXPRESSION TAG SEQRES 1 A 455 GLY PRO GLY SER MET VAL GLU GLN ILE LEU ALA GLU PHE SEQRES 2 A 455 GLN LEU GLN GLU GLU ASP LEU LYS LYS VAL MET ARG ARG SEQRES 3 A 455 MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU GLU THR SEQRES 4 A 455 HIS GLU GLU ALA SER VAL LYS MET LEU PRO THR TYR VAL SEQRES 5 A 455 ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP PHE LEU SEQRES 6 A 455 SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL MET LEU SEQRES 7 A 455 VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SER VAL SEQRES 8 A 455 LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU ASP ALA SEQRES 9 A 455 MET THR GLY THR ALA GLU MET LEU PHE ASP TYR ILE SER SEQRES 10 A 455 GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN MET LYS SEQRES 11 A 455 HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER PHE PRO SEQRES 12 A 455 VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU LEU ASN SEQRES 13 A 455 TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU GLY ASN SEQRES 14 A 455 ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS ARG ARG SEQRES 15 A 455 GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL ASN ASP SEQRES 16 A 455 THR VAL ALA THR MET ILE SER CYS TYR TYR GLU ASP HIS SEQRES 17 A 455 GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY CYS ASN SEQRES 18 A 455 ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU LEU VAL SEQRES 19 A 455 GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR GLU TRP SEQRES 20 A 455 GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU PHE LEU SEQRES 21 A 455 LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER ALA ASN SEQRES 22 A 455 PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY GLY LYS SEQRES 23 A 455 TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU ARG LEU SEQRES 24 A 455 VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SER GLU SEQRES 25 A 455 GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG PHE VAL SEQRES 26 A 455 SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS GLN ILE SEQRES 27 A 455 TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SER THR SEQRES 28 A 455 THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SER VAL SEQRES 29 A 455 SER THR ARG ALA ALA HIS MET CYS SER ALA GLY LEU ALA SEQRES 30 A 455 GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER GLU ASP SEQRES 31 A 455 VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER VAL TYR SEQRES 32 A 455 LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS ALA SER SEQRES 33 A 455 VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR PHE ILE SEQRES 34 A 455 GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA LEU VAL SEQRES 35 A 455 SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU GLY GLN HET GLC A 1 12 HET B84 A 466 37 HET NA A 467 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM B84 (2R)-3-CYCLOPENTYL-N-(5-METHOXY[1,3]THIAZOLO[5,4- HETNAM 2 B84 B]PYRIDIN-2-YL)-2-{4-[(4-METHYLPIPERAZIN-1-YL) HETNAM 3 B84 SULFONYL]PHENYL}PROPANAMIDE HETNAM NA SODIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 3 B84 C26 H33 N5 O4 S2 FORMUL 4 NA NA 1+ FORMUL 5 HOH *276(H2 O) HELIX 1 1 MET A 15 ALA A 21 1 7 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 ARG A 46 1 21 HELIX 4 4 THR A 49 ALA A 53 5 5 HELIX 5 5 PRO A 111 THR A 116 1 6 HELIX 6 6 THR A 118 HIS A 137 1 20 HELIX 7 7 ASN A 180 GLY A 193 1 14 HELIX 8 8 ASN A 204 ASP A 217 1 14 HELIX 9 9 GLN A 239 VAL A 241 5 3 HELIX 10 10 GLU A 256 PHE A 260 5 5 HELIX 11 11 LEU A 271 SER A 280 1 10 HELIX 12 12 TYR A 289 ILE A 293 5 5 HELIX 13 13 GLY A 294 GLU A 312 1 19 HELIX 14 14 LEU A 315 GLU A 319 5 5 HELIX 15 15 GLU A 331 GLU A 339 1 9 HELIX 16 16 ARG A 345 THR A 354 1 10 HELIX 17 17 SER A 360 GLU A 395 1 36 HELIX 18 18 GLY A 410 HIS A 416 1 7 HELIX 19 19 SER A 418 LEU A 430 1 13 HELIX 20 20 GLU A 443 ALA A 460 1 18 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O ASN A 254 N LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N TYR A 234 O VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N ILE A 225 O ASN A 231 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N VAL A 222 SHEET 6 A 6 CYS A 434 GLU A 440 1 O ILE A 439 N VAL A 408 SHEET 1 B 5 SER A 100 SER A 109 0 SHEET 2 B 5 ASN A 83 GLY A 92 -1 N LYS A 90 O LYS A 102 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N PHE A 74 O VAL A 89 SHEET 4 B 5 LEU A 144 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 MET A 197 VAL A 203 1 O ASP A 198 N LEU A 146 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 LINK O MET A 238 NA NA A 467 1555 1555 2.47 LINK O VAL A 241 NA NA A 467 1555 1555 2.48 LINK O VAL A 244 NA NA A 467 1555 1555 2.36 LINK O GLY A 246 NA NA A 467 1555 1555 2.50 LINK NA NA A 467 O HOH A 694 1555 1555 2.56 CRYST1 45.500 90.300 116.200 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021978 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008606 0.00000